AOA 2023: Diving into new data on MiSight contact lenses for myopia management
At AOA Optometry's Meeting 2023, in Washington, DC, Justin Kwan, OD, FAAO, provides updates on the latest at CooperVision, including new data on MiSight myopia management contact lenses and information on their ortho-K software, Visavy.
AOA 2023: Stay current with the updated AMD landscape
Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "AMD updates: Staying current with its landscape," which he co-presented with Jay Haynie, OD, FAAO.
AOA 2023: Eyechiatry: The psychology of vision loss
Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "Do you practice Eyechiatry? The psychology of vision loss," which he co-presented with Roya Attar, OD, MBA.
AOA 2023: Take a look into white dot syndrome
Roya Attar, OD, discussed, "White dot syndrome: More common than you think," which she will be presenting at AOA 2023 in Washington, DC.
A peek into the history of the International Keratoconus Academy
Andrew Morgenstern, OD, FAAO, FNAP, gives a brief history of the International Keratoconus Academy of Eye Care Professionals.
AOA 2023: 12 new treatments optometrists should know about
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.
AOA 2023: Surgical interventions should be considered earlier in glaucoma treatment
Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.
AOA 2023: Push for diversity, equity, and inclusion in optometry
Charissa Lee discusses diversity, equity, and inclusion within her role at Johnson & Johnson Vision and in the industry overall.
AOA 2023: Pharmaceutical treatment of anterior segment inflammatory conditions
Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.
AOA 2023: Clinical study gives AMD patients possible new treatment
Jeffry Gerson, OD, FAAO, who presented a poster on the Light Site 3 clinical study at the AOA online e-poster event, discusses a promising new treatment for patients with AMD.
ASCRS 2023: Laser scleral microporation from Ace Vision Group
Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.
ASCRS 2023: Aurion clinical trials of endothelial cell therapy injection
John Berdahl, MD, discussed the Aurion clinical trials of endothelial cell therapy injection at the 2023 ASCRS annual meeting in San Diego.
ASCRS 2023: Protecting against eye injuries in sports
Lori Pacheco, RN, CRNO, discussed sports-related eye injuries and how to prevent them at the 2023 ASCRS annual meeting in San Diego.
ASCRS 2023: The introduction of SeeLuma and more
Anthony Wallace, Vice President and General Manager of the US Surgical Business at Bausch + Lomb, discussed the introduction of SeeLuma, a fully digital surgical visualization platform, and more at the 2023 ASCRS annual meeting in San Diego.
DR:EAM study: Exploring eye drops for diabetic retinopathy
The DR:EAM study in investigating novel eye drop OTT-166 for the treatment of diabetic retinopathy in hopes of reducing treatment burden for patients.
ASCRS 2023: The safety of office space cataract surgeries
Lance Kugler, MD, recapped his presentation and findings on the safety of office space cataract surgery with the Ophthalmology Times© team at the ASCRS annual meeting in San Diego.
ASCRS 2023: Analysis in two subgroups of routine cataract surgery
Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.
ASCRS 2023: Progressive keratoconus in older patients with delayed corneal cross-linking treatment
William Trattler, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on progressive keratoconus in older patients with delayed corneal cross-linking treatment at the ASCRS annual meeting in San Diego.